“Based on the research we have done, perhaps as many as 3% of parents decline vaccines primarily due to the use of human fetal cells in the manufacturing. The viruses for the chickenpox and the hepatitis A vaccines are manufactured in the MRC-5 cell line, which was derived from a normal three and a half month old male fetus, while the rubella virus in the MMR II vaccine is manufactured in the WI-38 cell line, which was derived from a normal three-month female fetus.
In taking on the mission to provide alternative vaccines to those who object to the use of human fetal cell lines for vaccine production on a moral basis, we began to study the literature surrounding vaccines. The vaccine-autism controversy is difficult to miss, and simply reading the published literature should immediately arouse curiosity in a fresh and objective perspective mind.
Firstly, even in the publications that claim no link between MMR and autism, there is an evident autism change-point in 1988. The authors dismiss the link between autism and the MMR vaccine, in these publications, because, as they point out, vaccine compliance was already well over 95% in the UK before 1988. However, what the authors documented (on page 4, top right, which is appendix L of our binders), but failed to investigate, was that the MMR vaccine used in the UK was switched in 1988 and 1989.
Prior to 1988, the MMR in the UK was produced in animal cell lines, and in 1988 and 1989 three new MMRs replaced that original MMR—all of which use human fetal cell lines for the production of at least one of the viruses contained in the MMR. Having worked in commercial biotechnology and clinical development programs, I was aware of the residuals that would be found in vaccines. And having also worked with homologous recombination and molecular biology, I was also aware that the human fetal DNA introduced in vaccines has the potential to elicit autoimmune responses or to incorporate into the recipient’s own genes and disrupt normal protein production.
Inflection points, change points, are clear by eye in US autism prevalance data from the Department of Education, as well as from the California Department of Developmental Services. This intriguing and perplexing visual assessment of US autism prevalence, together with publications on autism rates in the UK, led Sound Choice (soundchoice.org) to more fully investigate. What we have found is that, across continents and across decades, changes in autism disorder—not considering autism spectrum, but only autism disorder—are clearly associated with the introduction of vaccines produced using human fetal cell lines.
Each time we inject our children with one of these vaccines, we are also injecting them with residual fetal human DNA.
… I’ve already mentioned that the UK 1988 birth year change-point in autism disorder is associated with the switch from animal to human fetal produced MMR. In the US, the switch was first approved in late-1979, and by 1983 only the human fetal produced MMR II was available in the US, coinciding with the 1981 birth year change-point for autism.”
— Theresa Deisher, PhD, molecular and cellular physiology at Stanford University